The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity
Ryan E. Watkins, G. Bruce Wisely, Linda B. Moore et al. · Science · 2001
The human nuclear pregnane X receptor (hPXR) activates cytochrome P450-3A expression in response to a wide variety of xenobiotics and plays a critical role in mediating dangerous drug-drug interactions. We present the crystal structures of the ligand-binding domain of hPXR both alone and in complex with the cholesterol-lowering drug SR12813 at resolutions of 2.5 and 2.75 angstroms, respectively. The hydrophobic ligand-binding cavity of hPXR contains a small number of polar residues, permitting SR12813 to bind in three distinct orientations. The position and nature of these polar residues were found to be critical for establishing the precise pharmacologic activation profile of PXR. Our findings provide important insights into how hPXR detects xenobiotics and may prove useful in predicting and avoiding drug-drug interactions.
Cited by 760 works. doi:10.1126/science.1060762
Authors
- Ryan E. Watkins
- G. Bruce Wisely
- Linda B. Moore
- Jon L. Collins
- Millard H. Lambert
- Shawn P. Williams
- Timothy Mark Willson
- Steven A. Kliewer
- Matthew R. Redinbo
References
- MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
- Improved methods for building protein models in electron density maps and the location of errors in these models
- Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
- Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
- [26] Raster3D: Photorealistic molecular graphics
- Improved Fourier coefficients for maps using phases from partial structures with errors
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
- Molecular basis of agonism and antagonism in the oestrogen receptor
- The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
- Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ